Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.

Antonio Quintana, Ewa Raczka, Lars Piehler, Inhan Lee, Andrzej Myc, Istvan Majoros, Anil K Patri, Thommey Thomas, James Mulé, James R Baker

Journal: Pharmaceutical research 2003;19(9):1310-6

PMID: 12403067

Abstract

PURPOSE

We sought to develop nanoscale drug delivery material that would allow targeted intracellular delivery while having an imaging capability for tracking uptake of the material. A complex nanodevice was designed and synthesized that targets tumor cell through the folate receptor.

METHODS

The device is based on an ethylenediamine core polyamidoamine dendrimer of generation 5. Folic acid, fluorescein, and methotrexate were covalently attached to the surface to provide targeting, imaging, and intracellular drug delivery capabilities. Molecular modeling determined the optimal dendrimer surface modification for the function of the device and suggested a surface modification that improved targeting.

RESULTS

Three nanodevices were synthesized. Experimental targeting data in KB cells confirmed the modeling predictions of specific and highly selective binding. Targeted delivery improved the cytotoxic response of the cells to methotrexate 100-fold over free drug.

CONCLUSIONS

These results demonstrate the ability to design and produce polymer-based nanodevices for the intracellular targeting of drugs, imaging agents, and other materials.

Address: Center for Biologic Nanotechnology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor 48109-0648, USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.